Phospho-Src Family (Tyr416) Antibody [D13C8]

N° de catalogue F4136

Imprimer

Description biologique

Spécificité Phospho-Src Family (Tyr416) Antibody [D13C8] détecte les niveaux endogènes de la protéine Src totale uniquement lorsqu'elle est phosphorylée en Tyr416.
Contexte Phospho-Src Family (Tyr416) désigne l'état activé des kinases de la famille Src (SFK), y compris Src, Lyn, Fyn, Yes, Lck, Blk et Hck, des tyrosines kinases non-réceptrices qui régulent la croissance cellulaire, la différenciation, la survie et la transduction du signal à partir des récepteurs de surface cellulaire. Les SFK partagent une architecture conservée avec un site de myristoylation N-terminal pour l'ancrage membranaire, un domaine unique, des domaines SH3 et SH2 pour les interactions protéine et phosphotyrosine, et un domaine kinase C-terminal (SH1) contenant la boucle d'activation avec Tyr416 (Tyr419 chez Src humain). La phosphorylation en Tyr416, typiquement par autophosphorylation intermoléculaire, stabilise la boucle d'activation dans une conformation ouverte et catalytiquement active, augmentant l'activité kinase jusqu'à 20 fois et favorisant la phosphorylation des substrats en aval. Cette phosphorylation activatrice est contrebalancée par une phosphorylation inhibitrice en Tyr530 C-terminale (Tyr527 chez le poulet), qui favorise la liaison SH2 intramoléculaire et un état kinase inactif ; la déphosphorylation de Tyr530 et la phosphorylation de Tyr416 activent conjointement les SFK. Dans cet état, les kinases Phospho-Src Family (Tyr416) médient divers processus cellulaires, notamment la prolifération, le réarrangement cytosquelettique pour la migration et l'adhésion, la signalisation immunitaire (telle que l'activation des lymphocytes T via Lck) et la régulation de l'apoptose, tandis qu'une activation persistante par dérégulation contribue à la progression du cancer et à une signalisation oncogénique soutenue.

Informations dutilisation

Application WB, IP Dilution
WB IP
1:1000 1:100
Réactivité Human, Mouse, Rat
Source Rabbit Monoclonal Antibody MW 60 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/31331936/
  • https://pubmed.ncbi.nlm.nih.gov/27387461/

Données dapplication

WB

Validé par Selleck

  • F4136-wb
    Lane 1: C6, Lane 2: C6 (Pervanadate, 0.5 mM, 37℃, 40 min)